Biolab Holdings, Inc. is a biotechnology company based in Arizona that develops products used in healthcare. Its lobbying filings show it focuses on Medicare and Medicaid and general health policy, especially rules and payment for skin substitutes and support for H.R. 5768, the Skin Substitute Access and Payment Reform Act. It has reported about $90,000 in lobbying and used Capitol Strategies, LLC.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
mr STEVEN W BLOCH
The latest disclosures for this client.
CAPITOL STRATEGIES, LLC
Q3CAPITOL STRATEGIES, LLC
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CAPITOL STRATEGIES, LLC
CAPITOL STRATEGIES, LLC
Q1CAPITOL STRATEGIES, LLC
Q4CAPITOL STRATEGIES, LLC
Q3CAPITOL STRATEGIES, LLC
Q2CAPITOL STRATEGIES, LLC
1ACAPITOL STRATEGIES, LLC
Q1